Keep pulling the thread on Nic Aldrich.
The FDA has granted clearance for Ortholine's Lantern ASC system.
Ortholine is the market leader in handheld orthopedic technologies.
Ortholine's products have been used in over 450,000 procedures globally since the company's inception.
Ortholine provides handheld navigation technologies for total hip, total knee, partial knee, and ligament balancing in the revision space.
Ortholine's Lantern ASC system is a purpose-built system designed specifically for the Ambulatory Surgery Center (ASC) market.
According to Nic Aldrich, Medicare policy is driving an increasing number of hip and knee procedures into Ambulatory Surgery Centers (ASCs).
Nic Aldrich believes that while orthopedic robotics have been in the market for over 10 years and advanced care, they have also introduced economic issues and time/throughput challenges.
One of Ortholine's biggest challenges is scaling its organization to capitalize on the market trends of technology adoption and the movement of procedures to surgery centers.
Ortholine operates through a distribution model, which creates a challenge in gaining mindshare from sales representatives who may also carry competing products.
Nic Aldrich states that large capital equipment in orthopedics, such as big box navigation or robotics, often comes with a price tag ranging from several hundred thousand dollars to half a million dollars.
Ortholine's technology is designed to be implant-agnostic, working with any implant system regardless of the surgeon's preferred technique or approach.